The Scottish government and Pharmaceutical Product Development, LLC (PPD) announced a unique alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance health care treatment options for the people of Scotland.
The US-based contract research organisation (CRO) has a longstanding relationship with the Scottish government and employs more than 300 clinical research professionals at its facility in Bellshill, Lanarkshire.
PPD will work closely with the major health boards across Scotland to further reduce study start-up times, streamline regulatory approval processes, increase the number of patients recruited for clinical trials and ensure the availability of resources and training to increase the number of physicians and support staff conducting research.
